Drawing for TILDA RESEARCH

USPTO serial 98297730

TILDA RESEARCH

Reviewed by CopyMark Law Group

Reg. 7750119Status 700Registered
Filing date
Status date
Registration date
Apr 8, 2025
Examiner
FRUM MILONE, MARCIE R
Law office
FILE REPOSITORY (FRANCONIA)

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with TILDA RESEARCH?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Ryan Roberts

550 Reserve Street Suite 390Southlake, TX 76092United States

Goods and services

ClassDescriptionStatusFirst use
035Business consulting and management in the field of clinical trials, namely, providing information management services, recordkeeping, workflows, and query managementACTIVEJun 25, 2019
042Providing information in the field of clinical research via a website; Consulting services for others in the field of design, planning, and implementation project management of clinical trials, including query management; Platform as a service (PAAS) featuring computer software platforms for use in running, managing and analyzing clinical trials, namely, enabling providers to create and scale clinical research capabilities and bring scientific advancements to patients; Platform as a service (PAAS) featuring computer software platforms for use in manage and/or participate in clinical research, query management and view data analytics; Platform as a service (PAAS) featuring computer software platforms for use in bringing trained clinical research personnel to run clinical trials; Providing a website featuring non-downloadable software for use in clinical research analytics and data capture forms; Providing medical and scientific research information in the field of clinical trialsACTIVEJun 25, 2019

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Apr 8, 2025NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Apr 8, 2025R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Feb 18, 2025NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Feb 18, 2025PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Feb 12, 2025NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jan 24, 2025CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jan 23, 2025TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jan 23, 2025CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jan 23, 2025TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jan 23, 2025NREVNOTICE OF REVIVAL - E-MAILED—
Jan 23, 2025PETGPETITION TO REVIVE-GRANTED—
Jan 23, 2025PROATEAS PETITION TO REVIVE RECEIVED—
Dec 4, 2024MAB2ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPONDThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Dec 4, 2024ABN2ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSEThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Oct 1, 2024DOCKASSIGNED TO EXAMINER—
Jul 3, 2024GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jul 3, 2024GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jul 3, 2024CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jul 2, 2024DOCKASSIGNED TO EXAMINER—
Feb 28, 2024NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Dec 4, 2023NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance